US 10307476
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 10307476 (Genetically stable live attenuated respiratory syncytial virus vaccine and its production) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/5254, A61K39/12, A61K39/155